Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01227122
Other study ID # 2010-A00111-38
Secondary ID
Status Recruiting
Phase N/A
First received October 22, 2010
Last updated March 1, 2013
Start date August 2010
Est. completion date September 2013

Study information

Verified date March 2013
Source Hopital Jean Minjoz
Contact n/a
Is FDA regulated No
Health authority France: Agence Française Sécurité Sanitaire des Produits de Santé (AFSSAPS)
Study type Observational

Clinical Trial Summary

Primary endpoint: To evaluate predictive value of plasmatic levels of Neutrophil Gelatinase Associated Lipocalin (NGAL) to reveal acute kidney failure after cardiac surgery in patients with preoperative chronic kidney failure Secondary endpoint is to obtain threshold values of NGAL.


Description:

(N/A)


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 2013
Est. primary completion date July 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Renal clearance less than 60 mL/min

- Able to give written consent

- Elective valve surgery

- Elective CABG surgery

Exclusion Criteria:

- Less than 18 years old

- Iodine injection within 3 days before surgery

- Iodine injection within 24 first postoperative hours

- preoperative infection

- evolutive cancer disease

- Refusal

- Pregnancy

- Unable to give written consent

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
France Centre hospitalier Universitaire (CHU) Jean Minjoz Besançon Franche-Comté

Sponsors (1)

Lead Sponsor Collaborator
Hopital Jean Minjoz

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neutrophil Gelatinase Associated Lipocalin (NGAL) level From surgery to discharge from hospital No
See also
  Status Clinical Trial Phase
Terminated NCT04293744 - Acute Kidney Injury After Cardiac Surgery N/A
Completed NCT01184521 - Masimo CO-Oximeter Study Phase 0
Completed NCT05537168 - Bayesian Networks in Pediatric Cardiac Surgery
Completed NCT04269109 - Opioid Sparing Pain Management Strategy
Completed NCT05737147 - Comparison of the Accuracy and Precision of a Zero Heat Flux Thermometer (SpotOn) Versus Pulmonary Artery Temperature.
Completed NCT04911413 - Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery Phase 4
Recruiting NCT02580292 - Diagnostic Accuracy of Doppler Resistive Indices for Early Diagnosis of Acute Kidney Injury .
Completed NCT02457572 - Pulse Pressure Variation Measured During Valsalva Maneuver to Predict Fluid Responsiveness Under Open-chest Condition N/A
Completed NCT00997217 - The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery Phase 1
Recruiting NCT05454735 - Glycemic Variability and Autonomic Nervous System in Cardiac Surgery Patients
Completed NCT01169441 - Lead Extract Study N/A
Completed NCT00336908 - Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery Phase 2/Phase 3
Terminated NCT05308589 - CPPF After General Cardiac Surgery N/A
Recruiting NCT03163238 - Dexmedetomidine and the Inflammatory Response in Pediatric Cardiac Surgery Phase 2
Completed NCT02329158 - Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery
Completed NCT01029314 - Pilot Study of the Genius(TM)2 Tympanic Thermometer in Cardiac Patients Requiring Cardiopulmonary Bypass N/A
Completed NCT00459082 - A Pharmacokinetic Study of Dexmedetomine in Infants Phase 1
Completed NCT00122018 - An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery Phase 2
Terminated NCT03709693 - Clinical Outcomes in Patients Treated With SternaLock Blu
Completed NCT03976947 - Impact of Lung Recruitment Maneuvers on Driving Pressure in Cardiac Surgery